Aspire Biopharma Holdings, Inc.
NASDAQ: ASBPW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kraig T. Higginson
- Employees
- 2
- Headquarters
- Humacao, United States
- IPO year
- 2022
- Market cap
- $230.0K
- Website
- https://aspirebiolabs.com
Loading ASBPW…
Loading profile data…Frequently asked questions about ASBPW
What does Aspire Biopharma Holdings, Inc. (ASBPW) do?
Aspire Biopharma Holdings, Inc. operates as a biotechnology enterprise primarily focused on innovative diagnostic approaches and molecular analysis. The company's core mission involves engineering remarkably precise testing tools for the identification of various illnesses, utilizing breakthroughs in genetic and biochemical science to serve the...
Where does ASBPW trade?
Aspire Biopharma Holdings, Inc. (ASBPW) trades on the NASDAQ Global Market.
What sector is ASBPW in?
Aspire Biopharma Holdings, Inc. (ASBPW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Aspire Biopharma Holdings, Inc.?
Kraig T. Higginson is the chief executive officer of Aspire Biopharma Holdings, Inc. (ASBPW).
Where is Aspire Biopharma Holdings, Inc. headquartered?
Aspire Biopharma Holdings, Inc. is headquartered in United States.
Does ASBPW pay a dividend?
Aspire Biopharma Holdings, Inc. (ASBPW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ASBPW go public?
Aspire Biopharma Holdings, Inc. (ASBPW) completed its initial public offering in 2022.